|
2025
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
Invention
|
Fulvestrant formulations.
Long term storage stable fulvestrant-containing compositions are discl... |
|
|
Invention
|
Formulations of bendamustine.
Long term storage stable bendamustine-containing compositions are ... |
|
|
Invention
|
Formulations of bendamustine. Long term storage stable bendamustine-containing compositions are d... |
|
2024
|
G/S
|
Pharmaceuticals for the treatment of cancer |
|
|
Invention
|
Use of remimazolam for pediatric sedation. The application is directed to methods of sedating a p... |
|
2023
|
Invention
|
Fulvestrant formulations.
Fulvestrant formulations suitable for intramuscular injection at conce... |
|
|
Invention
|
Pemetrexed formulations. The present invention is directed to pemetrexed formulations comprising ... |
|
|
Invention
|
Pemetrexed formulations.
The present invention is directed to pemetrexed formulations comprising... |
|
|
Invention
|
Formulations of bendamustine.
Methods of treatment using bendamustine formulations designed for ... |
|
|
Invention
|
Fulvestrant formulations and methods of their use. The present disclosure provides methods of tre... |
|
2021
|
Invention
|
Methods of using dantrolene to treat nerve agent exposure.
The disclosure is directed to methods... |
|
|
Invention
|
Fulvestrant formulations. Long term storage stable fulvestrant-containing compositions are disclo... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Fulvestrant formulations and methods of their use. The disclosure is directed to fulvestrant form... |
|
|
Invention
|
Methods of treating viral infections.
The disclosure is directed to methods of using dantrolene ... |
|
|
Invention
|
Methods of treating severe acute respiratory syndrome.
The disclosure is directed to methods of ... |
|
|
Invention
|
Methods of treating sars-cov-2 infections.
The disclosure is directed to methods of using dantro... |
|
|
Invention
|
Methods of treating coronavirus infections.
The disclosure is directed to methods of using dantr... |
|
|
Invention
|
Methods of treating sars-cov-2 infections. The disclosure is directed to methods of using dantrol... |
|
|
Invention
|
Methods of treating severe acute respiratory syndrome. The disclosure is directed to methods of u... |
|
|
Invention
|
Methods of treating coronavirus infections. The disclosure is directed to methods of using dantro... |
|
|
Invention
|
Methods of treating viral infections. The disclosure is directed to methods of using dantrolene o... |
|
2020
|
G/S
|
Pharmaceutical preparations for treatment of lung cancer |
|
2019
|
Invention
|
Use of dantrolene and dantrolene prodrugs to treat radiation exposure. The disclosure is directed... |
|
|
Invention
|
Dantrolene formulations and methods of their use.
The disclosure is directed to liquid formulati... |
|
|
Invention
|
Dantrolene formulations and methods of their use. The disclosure is directed to liquid formulatio... |
|
|
G/S
|
Printed educational materials, namely, circulars, brochures
and pamphlets on medical conditions,... |
|
2018
|
G/S
|
Printed educational materials, namely, circulars, brochures and pamphlets on medical conditions, ... |
|
2014
|
G/S
|
Commercialization of pharmaceutical products, namely, marketing in the field of pharmaceutical pr... |
|
2006
|
G/S
|
Dantrolene preparations for pharmaceutical purposes |
